Epidermal growth factor receptor (EGFR), a tyrosine kinase receptor regulating cell proliferation, survival, and migration, is frequently mutated or overexpressed in various tumors, especially in non-small cell lung cancer (NSCLC), driving tumor progression and therapy resistance [34,35]. The gene discussed is EGFR; the disease is neoplasm.